Volume: 71 - Number: 3 - year 2000



Summary   





EDITOR'S CHOICE
Diana N. J. Lockwood
DOI: 10.5935/0305-7518.20000025

    PDF



EDITORIAL

Remaining challenges towards elimination of leprosy
Maria P. Neira and D. Daumerie
DOI: 10.5935/0305-7518.20000026

    PDF



The global alliance for the elimination of leprosy (GAEL)
Terry Vasey
DOI: 10.5935/0305-7518.20000027

    PDF



Leprosy research in the new millennium in the Special Programme for Research and Training in Tropical Diseases (TDR)
Paul Nunn
DOI: 10.5935/0305-7518.20000028

    PDF



REVIEW

Monitoring motor nerve function in leprosy patients
J. Wim Brandsma
DOI: 10.5935/0305-7518.20000029

    PDF



SCIENCE COMMENTARY

Are cytokines our key to immunity against mycobacterial diseases?
Rosemary Weir
DOI: 10.5935/0305-7518.20000030

    PDF



COMMENTARY

A prospective corort study comes of age
Richard P. Croft
DOI: 10.5935/0305-7518.20000031

    PDF



PAPERS

The ALERT MDT Field Evaluation Study (AMFES): a descriptive study of leprosy in Ethiopia. Patients, methods and baseline characteristics
Paul Saunderson, Shibru Gebre, Ketsela Desta and Peter Byass
DOI: 10.5935/0305-7518.20000032

    PDF



The pattern of leprosy-related neuropathy in the AMFES patients in ethiopia: definitions, incidence, risk factors and outcome
Paul Saunderson, Shibru Gebre, Ketsela Desta, Peter Byass and Diana N. J. Lockwood
DOI: 10.5935/0305-7518.20000033

    PDF



Reversal reactions in the skin lesions of AMFES patients: incidence and risk factors
Paul Saunderson, Shibru Gebre and Peter Byass
DOI: 10.5935/0305-7518.20000034

    PDF



ENL reactions in the multibacillary cases of the AMFES cohort in central Ethiopia: incidence and risk factors
Paul Saunderson, Shibru Gebre and Peter Byass
DOI: 10.5935/0305-7518.20000035

    PDF



Relapses after fixed duration multiple drug therapy: the AMFES cohort
Shibru Gebre, Paul Saunderson and Peter Byass
DOI: 10.5935/0305-7518.20000036

    PDF



The pattern of decline in bacillary index after 2 years of WHO recommended multiple drug therapy: the AMFES cohort
Assefa Amenu, Paul Saunderson, Ketsela Desta and Peter Byass
DOI: 10.5935/0305-7518.20000037

    PDF



The effect of HIV status on the clinical picture of leprosy: a prospective study in Ethiopia
Shibru Gebre, Paul Saunderson, Tseha Ynesh Messele and Peter Byass
DOI: 10.5935/0305-7518.20000038

    PDF



The hand-foot impairment score as a tool for evaluating prevention of disability activities in leprosy: an exploration in patients treated with corticosteroids
S. M. Broekhuis, A. Meima, l. F. Koelewijn, J. H. Richardus, C. Benbow and P. R. Saunderson
DOI: 10.5935/0305-7518.20000039

    PDF



High dose prednisolone treatment of leprosy patients undergoing reactions is associated with a rapid decrease in urinary nitric oxide metabolites and clinical improvement
Thomas Schön, Ruth Leekassa, Negussie Gebre, Tommy Sundqvist, Elisabeth Bizuneh and Sven Britton
DOI: 10.5935/0305-7518.20000040

    PDF



Predisposing factors for recurrent skin ulcers in leprosy
Heinke Kunst
DOI: 10.5935/0305-7518.20000041

    PDF



Towards an understanding of non-compliance. An assessment of risk factors for defaulting from leprosy treatment
M. L. Heynders, J. J. Meijs and A. M. Anderson
DOI: 10.5935/0305-7518.20000042

    PDF



Modified leprosy elimination campaign (MLEC) for case detection in a remote tribal area in the State of Orissa, India
P. V. Ranganadha Rao, R. A. Bhuskade and K. V. Desikan
DOI: 10.5935/0305-7518.20000043

    PDF



CASE REPORT

Acro-osteolysis prior to diagnosis of leprosy
Ximena Illarramendi, Márcia R. Jarim, Ana M. Sales, José A. C. Nery and Euzenir N. Sarno
DOI: 10.5935/0305-7518.20000044

    PDF



'Wall Journal' on leprosy - a novel method to educate medical students
G. Shah, V. V. Pai, C. R. Revankar and R. Ganapati

    PDF



WHO leprosy elimination campaign - beyond 2005
K. L . Braber

    PDF



TEACHING MATERIALS
Alert training calendar 2001 • International course for Leprology Physicans • Asian Leprosy Congress • The Welcome Trust, London: Training Fellowships and Awards • The Robert Cochrane Fund for Leprosy • Access to reliable drug information in resource-poor countries • Public libraries in Africa • A report and annotated bibliography e videos on leprosy from who

    PDF



NEWS AND NOTES
The genome mapping of the leprosy bacillus completed e blocking natural killer cell activity • Alliance for Health Policy and Systems Research • AMREF: African Medical and Research Foundation • 'Molecular Pathology' edition of Journal Of Clinical Pathology (U.K.) •WHO Liaison: newsletter of the who library and information networks for knowledge • TDR: special initiatives to support academic programme development • The Heiser Program for Research in Leprosy and Tuberculosis • 'Drug-resistant tuberculosis can be controlled' says WHO • TB: a clinical manual for South East Asia • Global tuberculosis control: WHO report 1999 • What is DOTS? • Guidelines for the control of tuberculosis in prisons • INASP-Health e WHO: drugs used in HIV-related infections • AIDS cuts life expectancy in sub-Saharan Africa • St Joseph's Leprosy Hospital • Regional conferences of leprosy workers • Leprosy Focus Group for Podiatrists • Poster contest on leprosy (Hansen's disease)

    PDF